Jerrold Leikin to Drug Labeling
This is a "connection" page, showing publications Jerrold Leikin has written about Drug Labeling.
Connection Strength
0.828
-
The metoclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits. Am J Gastroenterol. 2013 Jun; 108(6):866-72.
Score: 0.443
-
A continuing black hole? The FDA boxed warning: an appeal to improve its clinical utility. Clin Toxicol (Phila). 2011 Jul; 49(6):443-7.
Score: 0.385